MENU

CNTX Context Therapeutics Forecast, Technical & Fundamental Analysis

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

CNTX is expected to report earnings to rise 5.60% to -10 cents per share on March 24

Context Therapeutics CNTX Stock Earnings Reports
Q4'26
Est.
$-0.11
Q3'26
Missed
by $0.01
Q2'26
Missed
by $0.06
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.04
The last earnings report on November 04 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 552.42K shares outstanding, the current market capitalization sits at 17.78M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGXX2.090.19
+9.74%
Digi Power X Inc
SNAL1.950.13
+7.14%
Snail Inc.
IRDM44.042.02
+4.81%
Iridium Communications
VALE11.590.14
+1.22%
Vale SA
COUR3.74-0.01
-0.27%
Coursera

CNTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTX has been loosely correlated with ELTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTX jumps, then ELTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
+2.98%
ELTX - CNTX
42%
Loosely correlated
+7.86%
NMRA - CNTX
39%
Loosely correlated
+3.35%
PROK - CNTX
29%
Poorly correlated
+7.04%
TRAW - CNTX
27%
Poorly correlated
+0.77%
MREO - CNTX
27%
Poorly correlated
+0.93%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
15
Web
https://www.contexttherapeutics.com